Abstract:OBJECTIVE:To evaluate retinoblastoma regression patterns following chemo reduction and adjuvant therapy.METHODS:Retrospective case series. 122 tumors of 47 eyes of 37 patients following chemo reduction and adjuvant therapy between January 2005 and June 2009 in the Eye & ENT hospital of Fudan University. Twenty-seven patients are male, and 10 patients are female. The average age was 22 months. The combined therapy included chemo reduction using vincristine, etoposide, and carboplatin (VEC) combined with local cryotherapy and/or transpupillary thermotherapy (TTT). The average follow-up duration was 32 months ranging from 12 to 60 months. Regression patterns included type 0 (no remnant), type 1 (calcified remnant), type 2 (noncalcified remnant), type 3 (partially calcified remnant), and type 4 (flat scar). Wilcoxon rank sum test was used to test the difference of tumor number between the patients with family history and those without family history. Chi-square test was used to test the difference between the tumor thickness, tumor location and regression patterns. Multivariate logistic regression analysis was used to test the correlation between the regression patterns and age, sex, tumor thickness, tumor location and family history. Statistical significance was assigned at P < 0.05.RESULTS:Forty-seven eyes according to the International Intraocular Retinoblastoma Classification, 20 eyes (42.6%) were group A, 13 eyes (27.6%) group B, 6 eyes (12.8%) group C, 8 eyes (17.0%) group D. Of 122 tumors, the average number of tumors per eye was 2.6. Retinoblastoma regressions were type 0 (n = 3), type 1 (n = 15), type 2 (n = 8), type 3 (n = 25), and type 4 (n = 71). Tumor thickness and tumor location were related to regression patterns. Tumors with an initial thickness of 2 mm or less regressed most often to type 4, and those thicker than 8 mm regressed to type 1 or type 3. Tumors with greater distance from the foveola regressed most often to type 4. The factors predictive of regression pattern type 1 included tumor thickness larger than 8 mm (Z = 3.02, P = 0.003). The factors predictive of regression pattern type 3 included older age, tumor thickness larger than 8 mm and location not in the equator to ora serrata region (Z = 3.98, 2.23, 3.60; P = 0.000, 0.025, 0.000). The factors predictive of regression pattern type 4 included familial hereditary pattern, tumor thickness smaller than 2 mm and location in the equator to ora serrata region. (Z = 4.37, 3.42, 2.42; P = 0.000, 0.000, 0.021). 12 tumors recurred, 9 tumors were type 3 and 3 tumors were type 4. 8 eyes developed 15 new tumors. 5 patients developed new tumors were all younger patients and had familial hereditary history. The average period of recurrence of main tumors and development of new tumors was six months after the end of chemo reduction.CONCLUSIONS:Following chemo reduction, type 3 and type 4 regression patterns were most common. Smaller tumors were usually seen in type 4, and bigger tumors were usually seen in type 1 or type 3. Tumor recurrence was usually found following regression pattern type 3 or type 4. Younger patients and patients with familial hereditary history trend to develop new tumors. Patients accept chemo reduction and adjuvant therapy need close follow-up.

Establishment Of The Relationship Between Tumor Size And Range Of Histological Involvement To Evaluate The Rationality Of Current Retinoblastoma Management

Clinical treatment and prognostic observation for different pathological infiltrations in 537 patients with unilateral retinoblastoma.

Histopathologic Risk Factors of Retinoblastoma: A Retrospective Study of 104 Enucleated Eyes

Impact of tumour size on metastasis and survival in patients with pancreatic neuroendocrine tumours (PNETs): A population based study.

Clinical Prognostic Factors for Central Neurocytoma and Subgroup Analysis of Different Treatment Measures: A SEER Database-Based Retrospective Analysis from 2003 to 2019

Analysis of the association between different treatments and high-risk histopathologic features of bilateral retinoblastomas

Treatment outcomes in retinoblastoma and the effect of tumor topography

Eye-Preserving Therapies for Advanced Retinoblastoma

Association of choroidal invasion with retinoblastoma survival rates

[The Efficacy of Large Spot Indirect Ophthalmoscopy Laser Alone or Combined with Systemic Chemotherapy in Retinoblastoma Therapy].

Retrospective clinical study on the comprehensive treatment of retinoblastoma

Retinoblastoma Regression Patterns and Results Following Chemoreduction and Adjuvant Therapy

Oseltamivir resistance during treatment of H7N9 infection

[Clinical Therapeutic Efficiency of Chemoreduction and Local Therapy for Children with Retinoblastoma].

Role of apparent diffusion map in the evaluation of retinoblastoma

Clinicopathological Analysis of 719 Pediatric and Adolescents’ Ocular Tumors and Tumor-Like Lesions: a Retrospective Study from 2000 to 2018 in China

[Clinicopathologic Features of Retinoblastoma and Expression of VEGF and Ki-67 after Comprehensive Treatment].

Multimodal imaging for the differential diagnosis and efficacy evaluation of intraocular retinoblastoma in children with selective ophthalmic artery infusion

Contemporary Update of Retinoblastoma in China: Three-Decade Changes in Epidemiology, Clinical Features, Treatments, and Outcomes

Radt-40. Evaluation Of Smaller Clinical Target Volumes And Patterns Of Progression In Patients With Newly Diagnosed Glioblastoma To Inform Future Directions In Radiation Treatment Planning

Outcome of Intra-Arterial Chemotherapy for Retinoblastoma and Its Influencing Factors: a Retrospective Study.